期刊文献+

心肌缺血对大鼠肾皮质利钠肽受体表达的影响

Effect of myocardial ischemia on the expression of natriuretic peptide receptor in renal cortex of rats
下载PDF
导出
摘要 目的探讨大鼠肾皮质利钠肽受体A(NPR-A)和受体C(NPR-C)的表达在心肌缺血后不同时程的动态变化。方法大鼠分为空白对照组、假手术组和模型组。分别于复制心肌缺血模型后的第3、7、14、18、28天取材,用Western blotting方法检测肾皮质内NPR-A和NPR-C的表达。结果在上述时间点上,肾皮质NPR-A的表达显著性降低(P<0.01),NPR-C表达呈现由缺血后第3天到缺血后第18天由低到高的波动变化,到缺血后第28天逐渐恢复至空白对照组水平。结论心肌缺血后,动物机体钠和水的滞留与NPR-A表达的降低以及NPR-C表达的升高密切相关。 Objetcive To investigate the changes of the expression levels of natriuretic peptide receptor A ( NPRA-) and C (NPR-C) in renal cortex after myocardial ischemia (MI) in rats.Methods All the rats were randomly divided into blank control group , sham-operation group and myocardial ischemia group .After MI models were established , the rats were sacrificed,and the expression levels of NPR-A and NPR-C in renal cortex were detected by Western blotting on day 3,7,14, 18,28.Results The expression levels of NPR-A in renal cortex were significantly decreased in different time points mentioned above ( P〈0.01),however,the expression levels of NPR-C were increased from day 3 to day 18,then,which gradually recovered to the levels in blank control group on day 28.Conclusion After myocardial ischemia ,the detention of sodium and water in the kidney of rats is closely correlated to the decrease of expression levels of NPR -A and the increase of expression levels of NPR-C.
出处 《河北医药》 CAS 2015年第4期500-503,共4页 Hebei Medical Journal
基金 河北省医学科学研究重点课题(编号:20090044)
关键词 心肌缺血 利钠肽受体 肾皮质 蛋白质印迹 大鼠 myocardial ischemia natriuretic peptide receptor renal cortex Western blotting rats
  • 相关文献

参考文献17

  • 1Pandey KN. Emerging Roles of Natriuretic Peptides and their Receptors in Pathophysiology of Hypertension and Cardiovascular Regulation. J Am Soc Hypertens,2008 ,2 :210-226.
  • 2Milik E, Szczepanska-Sadowska E, Dobruch J, et al. Altered expression of V1 a receptors mRNA in the brain and kidney after myocardial infarction and chronic stress. Neuropeptides ,2014,48:257-266.
  • 3Gao Y,Lv J,Lin Y,et al. Effects of beta -Adrenoceptor Subtypes on Car- diac Function in Myocardial Infarction Rats Exposed to Fine ParticulateMatter (PM 2.5 ). Biomed Res Int,2014 ,2014 :308295.
  • 4Liu Q. Lentivirus mediated interference of Caspase-3 expression amelio- rates the heart function on rats with acute myocardial infarction. Eur Rev Med Pharmacol Sci,2014,18:1852-1858.
  • 5刘红樱,王蔚,葛均波.B型利钠肽与急性冠状动脉综合征的研究进展[J].上海医学,2011,34(3):237-239. 被引量:3
  • 6牛丽静,白云,苗智慧,管振龙,夏晓红,王燕凌,王惠娟.心肌缺血对大鼠延髓利钠肽受体表达的影响[J].中国病理生理杂志,2014,30(2):220-225. 被引量:2
  • 7Potter LR, Yoder AR, Flora DR, et al. Natr/uretic peptides : their struc- tures, receptors, physiologic functions and therapeutic applications. Handb Exp Pharmacol,2009,29:341-366.
  • 8Niu JM, Ma ZL, Xie C, et al. Association of plasma B-type natriuretic peptide concentration with myocardial infarct size in patients with acute myocardial infarction. Genet Mol Res,2014,13:6177-6183.
  • 9Chien YW, Barbee RW, MacPhee AA, et al. Increased ANF secretion af- ter volume expansion is preserved in rats with heart failure. Am J Physiol, 1988,254:R185-191.
  • 10Drexler H, Finkh M, Hoing S, et al. Systemic and regional vascular effects of atrial natriuretic peptide in a rat model of chronic heart fail- ure. Basic Res Cardiol,1987 ,82 :517-529.

二级参考文献42

  • 1魏庆民,傅向华,范卫泽,谷新顺,李世强,姜云发,段江波.静脉应用重组人脑利钠肽对急性心肌梗死经皮冠状动脉介入治疗后患者心室重塑和左心功能的影响[J].中国全科医学,2007,10(8):615-617. 被引量:23
  • 2James S K, IAndahl B, Siegbahn A, et al. N-terminal pro- brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy. Circulation, 2003, 108: 275-281.
  • 3Hillock R J, Frampton C M, Yandle T G, et al. B-type natriuretic peptide infusions in acute myocardial infarction. Heart, 2008, 94. 617-622.
  • 4He J, Chen Y, Huang Y,et al. Effect of long-term B-type natriuretic peptide treatment on left ventricular remodeling and function after myocardial infarction in rats. Eur J Pharmacol, 2009, 602. 132 -137.
  • 5Richards A M, Nicholls M G, Espiner E A, et al. B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction. Circulation, 2003, 107:2786-2792.
  • 6Grabowski M, Filipiak K J, Malek I. A, et al. Admission B type natriuretic peptide assessment improves early risk stratification by Killip classes and TIMI risk score in patients with acute ST elevation myocardial infarction treated with primary angioplasty. Int J Cardiol, 2007, 115: 386-390.
  • 7Morrow D A, de Lemos J A, Sabatine M S, et al. Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non ST elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18. J Am Coil Cardiol, 2003, 41: 1264-1272.
  • 8Suzuki S, Yoshimura M, Nakayama M, et al. Plasma level of B-type natriuretic peptide as a prognostic marker after acute myocardial infarction: a long-term follow-up analysis. Circulation, 2004, 110: 1387-1391.
  • 9Westerhout C M, Fu Y, Lauer M S, et al. Short- and long term risk stratification in acute coronary syndromes: the added value of quantitative ST segment depression and multiple biomarkers. J Am Coll Cardiol, 2006, 48: 939-947.
  • 10Bazzino O, Fuselli J J, Botto F, et al. Relative value of N terminal probrain natriuretic peptide, TIMI risk score, ACC/ AHA prognostic classification and other risk markers in patients with non-ST-elevation acute coronary syndromes. Eur Heart J, 2004, 25:859 866.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部